Aluminum Hydroxide 160 mg / magnesium trisilicate 40 mg / NaHCO3 140 mg Chewable Tablet
RxNorm 307822
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 307822 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Aluminum Hydroxide 160 mg / magnesium trisilicate 40 mg / NaHCO3 140 mg Chewable Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Aluminum hydroxide 160 mg / magnesium trisilicate 40 mg / sodium bicarbonate 140 mg Chewable Tablet
(Atom ID: 12339050)
SY